FDA Inspection 1082602 — Matt Wayment

Matt Wayment — FEI 3014911283

The FDA completed an inspection of Matt Wayment on March 14, 2019 in Ogden, UT. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). 1 citation was issued during this inspection. Product area: Veterinary.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
March 14, 2019
Fiscal Year
2019
Product Type
Veterinary
Project Area
Monitoring of Marketed Animal Drugs, Feed, and Devices
Location
Ogden, UT (United States)

Citations

IDCFRDescription
4185FDCA 402(a)(4)Record keeping